drugset / Trial / NCT00259792

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00259792 ↗

Phase 3 Completed 1000 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the efficacy of a flexible dose of Symbicort with conventional stepwise treatment according to asthma treatment guidelines in patients with persistent asthma.

Timeline

Start
2004-09
Primary completion
—
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide/formoterol Unknown — Inhaled

Indications